643093-74-7 Usage
Uses
Used in Organic Synthesis:
2,3-DIMETHYL-4-FORMYLPHENYLBORONIC ACID is used as a building block for the synthesis of various pharmaceuticals and agrochemicals due to its ability to form carbon-carbon bonds through Suzuki-Miyaura cross-coupling reactions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2,3-DIMETHYL-4-FORMYLPHENYLBORONIC ACID is utilized for the formation of arylboronic esters and arylboronic acids, which are key intermediates in the development of new drugs.
Used in Drug Discovery and Development:
2,3-DIMETHYL-4-FORMYLPHENYLBORONIC ACID is used as a valuable tool in drug discovery and development, as it has been found to exhibit anti-inflammatory and anticancer activities, making it a promising candidate for the treatment of various diseases.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,3-DIMETHYL-4-FORMYLPHENYLBORONIC ACID is used as a key intermediate for the synthesis of various drugs, contributing to the development of novel therapeutic agents with improved efficacy and safety profiles.
Used in Agrochemical Industry:
In the agrochemical industry, 2,3-DIMETHYL-4-FORMYLPHENYLBORONIC ACID is used as a building block for the synthesis of agrochemicals, such as pesticides and herbicides, to enhance crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 643093-74-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,3,0,9 and 3 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 643093-74:
(8*6)+(7*4)+(6*3)+(5*0)+(4*9)+(3*3)+(2*7)+(1*4)=157
157 % 10 = 7
So 643093-74-7 is a valid CAS Registry Number.
643093-74-7Relevant articles and documents
AMINOALCOHOL DERIVATIVES
-
, (2008/06/13)
The present invention relates to a compound formula [I]: wherein Y is bond,--O--(CH2)n--(in which n is 1, 2, 3 or 4), etc., Z is cyano, tetrazolyl, etc., R1 is hydrogen, lower alkyl, etc., R2 is hydrogen or an amino protective group, R3 is hydrogen or lower alkyl, R4 is hydrogen or lower alkyl, R5 and R8 are each independently hydrogen, halogen, hydroxy, lower alkyl, etc., R6 is hydrogen, lower alkyl, etc., R9 is hydrogen or lower alkyl, and i is 1 or 2, or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.